BayWa r.e. Appoints Ken Lima as CEO of U.S. Solar Distribution Business
"Jodi has played an integral role at BayWa r.e. Solar Distribution for 16 years, including her role as a co-founder of the
Lima's strategic approach aligns with BayWa r.e.'s commitment to being an industry leader in support of its customers and partners across the
"Throughout my time in the renewable energy industry, I have observed BayWa r.e.'s commitment to driving positive change within the industry," said
White will transition into an advisory role to support
"Over the past two decades, I've had the privilege of witnessing the industry transform into a successful means of powering homes — a rewarding journey filled with valuable connections and growth," said
Leveraging over 25 years of experience in the photovoltaic market and collaboration with installers worldwide, BayWa r.e.'s solar distribution business has earned a reputation as a trusted industry leader. The company excels in high-quality products and availability, logistics expertise, technical training, customer support, online services, and partner services.
About BayWa r.e.
At BayWa r.e. we r.e.think energy -- how it is produced, stored and can be best used to enable the global renewable energy transition that is essential to the future of our planet. We are a leading global developer, service supplier, distributor and solutions provider and have brought over 5.5 GW of energy online and manage over 10 GW of assets. We are also an Independent Power Producer with an expanding energy trading business. BayWa r.e. works with businesses worldwide to provide tailored renewable solutions. Operating 100% carbon compensated, we are also committed to our own sustainability journey. Our shareholders are BayWa AG, a
View original content to download multimedia:https://www.prnewswire.com/news-releases/baywa-re-appoints-ken-lima-as-ceo-of-us-solar-distribution-business-302030427.html
SOURCE BayWa r.e. USA LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma
- Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering
- Micron Biomedical Honored with Georgia Life Sciences' Prestigious Phoenix Award for Transformative Research
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TeslaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share